Figure - available from: Journal of Thrombosis and Thrombolysis
This content is subject to copyright. Terms and conditions apply.
Glycoprotein IIb/IIIa inhibitor use and change in area stenosis and relative reduction of thrombus volume. The increase in area stenosis from baseline to 1-year follow-up was significantly smaller in patients with glycoprotein IIb/IIIa inhibitor (GPI) than that in patients without GPI (A). The relative reduction of thrombus volume (TV) was greater in patients treated with GPI than those without GPI (B)

Glycoprotein IIb/IIIa inhibitor use and change in area stenosis and relative reduction of thrombus volume. The increase in area stenosis from baseline to 1-year follow-up was significantly smaller in patients with glycoprotein IIb/IIIa inhibitor (GPI) than that in patients without GPI (A). The relative reduction of thrombus volume (TV) was greater in patients treated with GPI than those without GPI (B)

Source publication
Article
Full-text available
Organization of platelet-rich thrombus at the site of plaque disruption may contribute to rapid progression of atherosclerosis. This study was conducted to investigate if potent platelet inhibition therapy in patients with acute coronary syndromes (ACS) mitigates plaque progression. Patients enrolled in the EROSION study who presented with ACS caus...